ARTICLE | Company News

Activaero, Vectura deal

March 17, 2014 7:00 AM UTC

Pulmonary play Vectura Group is acquiring drug delivery company Activaero for €130 million ($180.6 million). The amount comprises €45 million ($62.5 million) up front in cash and €50 million ($69.5 million) in new Vectura shares, plus €35 million ($48.6 million) in a deferred cash payment. Activaero shareholders may also receive up to €6 million ($8.3 million) tied to future deals involving Activaero's technologies. Vectura is financing the cash portion of the deal with existing cash. ...